FIELD: pharmacology.
SUBSTANCE: present invention concerns compounds of formula I 
where R1 represents group R5S(O)2O wherein R5 represents group C1-10alkyl optionally substituted with one or more fluoro; R2a and R2b represent H or chloro; R3 represents group CONHNR7R8 wherein NR7R8 represents pyperidine-1-yl; and R4 represents group C1-3alkyl, and its pharmaceutically acceptable salts. Besides the invention concerns a pharmaceutical composition based on the compound of formula I and to application thereof in manufacturing of medicines possessing activity to CB1 receptor.
EFFECT: new imidazole derivatives expressing effective biological properties.
16 cl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 3-SUBSTITUTED 1,5-DIPHENYLPYRAZOLE EFFECTIVE AS CB1 MODULATORS | 2005 |
|
RU2375349C2 |
| SYNTHESIS AND USE OF TETRAHYDROPYROLLO[3,2-c]PYRIDIN-4-ONE DERIVATIVES TO TREAT OBESITY, PSYCHIATRIC AND NEUROLOGICAL DISORDERS | 2006 |
|
RU2415856C2 |
| 1-IMIDAZOLE DERIVATIVES AS MODULATORS OF CANNABINOID RECEPTORS | 2004 |
|
RU2337907C2 |
| PYRAZOLE DERIVATIVES | 2012 |
|
RU2600983C2 |
| TETRASUBSTITUTED IMIDAZOLE DERIVATIVES AS CANNABINOID CB RECEPTOR MODULATORS, HIGHLY SELECTIVE TO SUBRANGE RECEPTORS CB/CB | 2005 |
|
RU2354650C2 |
| CYCLOPROPYLPIPERIDINE GLYCINE TRANSPORTER INHIBITORS | 2005 |
|
RU2387644C2 |
| 1,2,4-TRIAZOLE DERIVATIVES AS SIGMA RECEPTOR INHBITORS | 2007 |
|
RU2451015C2 |
| DERIVATIVES OF 1H-IMIDAZOLE POSSESSING CB-AGONISTIC, PARTIAL CB-AGONISTIC OR CB-ANTAGONISTIC ACTIVITY | 2002 |
|
RU2299200C2 |
| HETEROAROMATIC COMPOUNDS AND THEIR APPLICATION AS DOPAMINE D1 LIGANTS | 2013 |
|
RU2617842C2 |
| CATECHOL-O-METHYLTRANSFERASE INHIBITORS AND THEREOF APPLICATION FOR TREATMENT OF PSYCHOTIC DISORDERS | 2011 |
|
RU2563634C2 |
